FLEA (psychedelic)
From Wikipedia, the free encyclopedia
 |
|
|
FLEA (psychedelic)
|
|
| Systematic (IUPAC) name | |
| N-(2-Benzo[1,3]dioxol-5-yl-1-methyl-ethyl)-N-methyl-hydroxylamine | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C11H15NO3 |
| Mol. mass | 209.24 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
FLEA, or 3,4-methylenedioxy-alpha,N-dimethyl-N-hydroxyphenethylamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is the N-hydroxy homolog of MDMA (Ecstasy). FLEA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 100-160mg, and the duration listed as 4-8 hours.[1] FLEA causes entactogenic, open MDMA-like effects and eases communication. It also increases appreciation of the senses. Very little data exists about the pharmacological properties, metabolism, and toxicity of FLEA.
[edit] References
- ^ Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
